摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-O-[(N-L-norvalyl)sulfamoyl]adenosine | 591766-25-5

中文名称
——
中文别名
——
英文名称
5'-O-[(N-L-norvalyl)sulfamoyl]adenosine
英文别名
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-[(2S)-2-aminopentanoyl]sulfamate
5'-O-[(N-L-norvalyl)sulfamoyl]adenosine化学式
CAS
591766-25-5
化学式
C15H23N7O7S
mdl
——
分子量
445.456
InChiKey
QTXQDMIBEAXONV-JVEUSOJLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    30
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    226
  • 氢给体数:
    5
  • 氢受体数:
    12

反应信息

  • 作为产物:
    描述:
    三氟乙酸 作用下, 以 为溶剂, 以38%的产率得到5'-O-[(N-L-norvalyl)sulfamoyl]adenosine
    参考文献:
    名称:
    Biosynthetic diversification of non-ribosomal peptides through activity-based protein profiling of adenylation domains
    摘要:
    与前体定向生物合成相结合,基于活性的非核糖体肽合成酶蛋白质分析为非核糖体肽的生物合成多样化提供了合理的指导。
    DOI:
    10.1039/d3cc02633g
点击查看最新优质反应信息

文献信息

  • ANTI-MICROBIAL AGENTS AND USES THEREOF
    申请人:Tan Derek Shieh
    公开号:US20090170805A1
    公开(公告)日:2009-07-02
    Many pathogens, including Mycobacterium tuberculosis and Yersinia pestis , rely on an iron acquisition system based on siderophores, secreted iron-chelating compounds with extremely high Fe(III) affinity. The compounds of the invention are inhibitors of domain salicylation enzymes, which catalyze the salicylation of an aroyl carrier protein (ArCP) domain to form a salicyl-ArCP domain thioester intermediate via a two-step reaction. The compounds include the intermediate mimic 5′-O—[N-(salicyl)sulfamoyl]-adenosine (salicyl-AMS) and analogs thereof. These compounds are inhibitors of the salicylate activity of MbtA, YbtE, PchD, and other domain salicylation enzymes involved in the biosynthesis of siderophores. Therefore, these compounds may be used in the treatment of infection caused by microorganisms which rely on siderphore-based iron acquisition systems. Pharmaceutical composition and methods of using these compounds to treat or prevent infection are also provided as well as methods of preparing the inventive compounds.
  • US8461128B2
    申请人:——
    公开号:US8461128B2
    公开(公告)日:2013-06-11
  • US8946188B2
    申请人:——
    公开号:US8946188B2
    公开(公告)日:2015-02-03
查看更多